Loading clinical trials...
Loading clinical trials...
Multicentre NIS Retrospective Study to Know the Prevalence of HER2- Low,Clinical Characteristics,Treatment Patterns,Associated Outcome in Patient With HER2-negative in Metastatic Breast Cancer Who Progressed on Systemic Anticancer Therapy
Conditions
Locations
31
Argentina
Research Site
Rosario, Argentina
Research Site
São Paulo, Brazil
Research Site
Santo Domingo, Dominican Republic
Research Site
Hong Kong, Hong Kong
Research Site
Bengaluru, Karnataka, India
Research Site
Kochi, Kerala, India
Start Date
April 23, 2024
Primary Completion Date
May 19, 2025
Completion Date
May 19, 2025
Last Updated
September 18, 2025
NCT07483307
NCT06625775
NCT06649331
NCT07379918
NCT04585750
NCT07112053
Lead Sponsor
AstraZeneca
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions